Literature DB >> 6086860

Technetium-99m pyrophosphate in diagnosis of acute cardiac rejection in the rat with effect of cyclosporine: concise communication.

C G McGregor, R Hatz, S Aziz, M B Billingham, I R McDougall.   

Abstract

Tc-99m pyrophosphate (PPi) uptake has been measured in a rat model of heterotopic heart transplant at 5 days after transplantation. comparison of tracer uptake, as a ratio between the heterotopic transplanted heart and the recipient's native heart, was made in four groups of animals. Group 1, with transplants between animals of isogeneic strain showed a lower ratio, significantly different from the ratio in Group 2 in which transplants were between nonisogeneic animals. The ratio of uptake after transplantation between nonisogeneic animals treated with 10 mg/kg-day of cyclosporine (Group 3), was not significantly different from Group 1. In contrast, the ratio of uptake between nonisogeneic animals treated with subtherapeutic doses of cyclosporine (Group 4), was not significantly different from Group 2. In Groups 1, 2, and 3 there was a correlation between the histology of the transplanted hearts, graded 1 to 5 according to the severity of rejection, compared with the uptake of Tc-99m PPi. This agent can therefore be used to diagnose cardiac rejection in a rat model, and the results correlate well with the severity of rejection as assessed histologically.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6086860

Source DB:  PubMed          Journal:  J Nucl Med        ISSN: 0161-5505            Impact factor:   10.057


  5 in total

1.  Indium-111 myosin-specific antibodies and technetium-99m pyrophosphate in the detection of acute cardiac rejection of transplanted hearts: studies in a heterotopic rat heart model.

Authors:  K Takeda; K Ueda; U Scheffel; H Ravert; N D LaFrance; W A Baumgartner; B A Reitz; A Herskowitz; H N Wagner
Journal:  Eur J Nucl Med       Date:  1991

2.  Identification of cardiac rejection with magnetic resonance imaging in heterotopic heart transplantation model.

Authors:  T Nishimura; M Sada; H Sasaki; C Yutani; T Kozuka; H Amemiya; T Fujita; T Akutsu; H Manabe
Journal:  Heart Vessels       Date:  1987       Impact factor: 2.037

3.  Cardiac transplantation in dogs: evaluation with gated MRI and Gd-DTPA contrast enhancement.

Authors:  T Nishimura; M Sada; H Sasaki; H Amemiya; T Kozuka; T Fujita; T Akutsu; H Manabe
Journal:  Heart Vessels       Date:  1987       Impact factor: 2.037

4.  Identification of cardiac rejection in heterotopic heart transplantation using 111In-antimyosin.

Authors:  T Nishimura; M Sada; H Sasaki; C Yutani; M Hayashi; H Amemiya; T Fujita; T Akutsu; H Manabe
Journal:  Eur J Nucl Med       Date:  1987

5.  201Tl myocardial perfusion in the management of the transplanted heart.

Authors:  J Richter; J Herreros; A Serena; M Domper; J C Ramirez; A Gómez; R Arcas
Journal:  Eur J Nucl Med       Date:  1990
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.